<DOC>
	<DOCNO>NCT01998425</DOCNO>
	<brief_summary>The investigator collect fibrocytes ( CD45+Col-1+ ) patient non-small cell lung cancer ( NSCLC ) . The investigator hypothesize patient NSCLC experience expansion immunosuppressive fibrocytes , predict augment tumor growth mediate immune escape NSCLC patient .</brief_summary>
	<brief_title>Circulating Fibrocytes Non-small Cell Lung Cancer .</brief_title>
	<detailed_description>Fibrocytes describe mice human , bear hematopoietic progenitor phenotype ( CD45+Col-1+ ) . Fibrocytes previously describe murine cancer , implicate mediator tumor immune escape . In study , investigator collect fibrocytes include CD45+Col-1+ expression . The cell express indoleamine oxidase , primarily responsible immunosuppressive property . The investigator hypothesize patient non-small cell lung cancer experience expansion immunosuppressive fibrocytes , predict augment tumor growth mediate immune escape non-small cell lung cancer patient .</detailed_description>
	<criteria>Histologically cytologically confirm nonsmall cell lung cancer ( NSCLC ) . Combination malignancy . Age le 20 year ( include 20 year ) . Pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>circulate fibrocytes</keyword>
	<keyword>fibrocyte</keyword>
	<keyword>NSCLC</keyword>
	<keyword>treatment response</keyword>
	<keyword>survival</keyword>
	<keyword>stage</keyword>
</DOC>